Clinical Presentation and Treatment Outcomes of Pupillary Block Glaucoma Following Vitreoretinal Surgery.


Journal

Seminars in ophthalmology
ISSN: 1744-5205
Titre abrégé: Semin Ophthalmol
Pays: England
ID NLM: 8610759

Informations de publication

Date de publication:
Jul 2024
Historique:
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 29 5 2024
Statut: ppublish

Résumé

To describe the clinical presentation and treatment outcomes of pupillary block glaucoma (PBG) following vitreoretinal surgery (VR surgery). Retrospective observational study of 6941 patients, who underwent VR surgery at a tertiary eye care centre in South India between January 2015 and December 2019. Amongst them, clinical data of 61 patients who developed PBG were taken for statistical analysis. Mean (SD) age was 53.90 (13.4) years and the incidence of PBG was .87%. Median (IQR) time of onset of PBG following VR surgery was 3.33 (1.1-6.6) months and majority were pseudophakic (75%). PBG resolved with Nd:YAG laser peripheral iridotomy (LPI) alone in 50 (82%) patients, whereas 11(18%) patients required additional interventions like surgical iridectomy, trabeculectomy or diode laser cyclophotocoagulation (CPC) either as a stand-alone procedure or in combination with silicone oil removal (SOR). Mean (SD) intraocular pressure at the onset of PBG was 41.61 (14.5) mmHg, which reduced drastically following LPI to 24.28 (14.9) mmHg which further dropped significantly at 6 months follow up to 20.34 (13.9) mmHg. Incidence of secondary PBG after VR surgery was .87%, and we observed diabetes mellitus, combined cataract and VR surgery, use of 1000cs SO endotamponade, intraoperative endolaser and multiple VR surgical interventions as common associations. Majority of the patients with PBG after VR procedures resolved with LPI and medical management. Few individuals (18%) required additional laser or surgical intervention for IOP control.

Identifiants

pubmed: 38810666
doi: 10.1080/08820538.2024.2323117
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-386

Auteurs

Vijayalakshmi A Senthilkumar (VA)

Department of Glaucoma, Aravind Eye Hospital and Postgraduate institute of ophthalmology, Madurai, Tamilnadu, India.

Narendra Wala (N)

Department of Glaucoma, Aravind Eye Hospital and Postgraduate institute of ophthalmology, Madurai, Tamilnadu, India.

Sharmila Rajendrababu (S)

Department of Glaucoma, Aravind Eye Hospital and Postgraduate institute of ophthalmology, Madurai, Tamilnadu, India.

Chitaranjan Mishra (C)

Department of Retina and Vitreoretinal surgery, Aravind Eye Hospital and Postgraduate Institute of ophthalmology, Madurai, Tamilnadu, India.

Naresh Babu Kannan (NB)

Head of the department, Department of Retina and Vitreoretinal surgery, Aravind Eye Hospital and Postgraduate Institute of ophthalmology, Madurai, Tamilnadu, India.

Mohammed Sithiq Uduman (MS)

Department of Biostatistics, Aravind Eye Hospital and Postgraduate Institute of ophthalmology, Madurai, Tamilnadu, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH